Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.43404 | 71 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.40202 | 70 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.42525 | 71 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.22994 | 68 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.3826 | 70 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.61857 | 73 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.78752 | 74 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.40491 | 70 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.4016 | 70 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.39954 | 70 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.40243 | 71 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.37406 | 70 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.45073 | 71 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.40871 | 71 |